Peptide-antifouling interface for monitoring β-amyloid based on electrochemiluminescence resonance energy transfer

In this study, a novel antifouling electrochemiluminescence (ECL) analytical platform has been developed for the highly sensitive quantification of β-amyloid (Aβ) peptides based on the ECL resonance energy transfer (ECL-RET) mechanism. Specifically, glassy carbon electrodes (GCE) were initially coated with graphite-phase carbon nitride (g-C3N4) nanosheets, followed by the electropolymerization of polyaniline (PANI) onto the electrode surface. Subsequently, a promising peptide motif candidate (COOH-CPPPPDKDKDKDKKLVFF) was immobilized onto the PANI-modified electrode, functioning as a critical component for both antifouling and specific recognition of full-length Aβ peptides. Furthermore, this peptide motif demonstrated inhibitory effects on Aβ aggregation and dissociation. Upon immobilization of the peptide motif, Aβ aptamer-CdS QDs were bound to the electrode surface through peptide-specific interactions with Aβ, thereby facilitating the highly sensitive ECL detection of Aβ. Under the optimal conditions, the proposed biosensor exhibited an Aβ detection range from 0.1 pM to 100 nM with a detection limit of 16.1 fM. As such, this innovative platform offers a straightforward approach to antifouling, quantification, and monitoring of Aβ concentrations in the blood samples.

One master and two servants: One Zr(Ⅳ) with two ligands of TCPP and NH2-BDC form the MOF as the electrochemiluminescence emitter for the biosensing application

Here we put forward an innovative "one master and two servants" strategy for enhancing the ECL performance. A novel ECL luminophore named Zr-TCPP/NH2-BDC (TCPP@UiO-66-NH2) was synthesized by self-assembly of meso-tetra(4-carboxyphenyl)porphine (TCPP) and 4-aminobenzoic acid (NH2-BDC) with Zr clusters. TCPP@UiO-66-NH2 has a porous structure and a highly ordered structure, which allows the molecular motion of TCPP to be effectively confined, thereby inhibiting nonradiative energy transfer. Importantly, TCPP@UiO-66-NH2 has a higher and more stable ECL signal. To further improve the sensitivity of the sensor, we use polydopamine-coated manganese dioxide (PDA@MnO2), which has a double quenching effect, as the quencher. The nucleocapsid (N) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2-N) is one of the ideal markers for the early diagnosis of COVID-19, and its sensitivity detection is of great significance for the prevention and treatment of COVID-19. Thus, we constructed a quenching-type ECL sensor for the ultrasensitive detection of the SARS-CoV-2-N. Its linear range is 10 fg/mL∼1 μg/mL and the calculated detection limit is 1.4 fg/mL (S/N = 3). The spiked recoveries are 97.40-103.8%, with the relative standard deviations (RSD) under 3.0%. More importantly, the technique offers a viable way to identify and diagnose viral infections early.

Electrochemiluminescence resonance energy transfer between Ru(bpy)32+@Cu3(HHTP)2 and GO-Au composites for C-reactive protein detection

Designing innovative electrochemiluminescence (ECL) immunosensors is critical for the detection of biomarkers with a low concentration and the precise evaluation of clinical diseases. Herein, a Cu₃(hexahydroxytriphenylene)₂ (Cu₃(HHTP)₂) nanoflake-based sandwich-type ECL immunosensor was constructed for C-Reactive Protein (CRP) detection. The Cu₃(HHTP)₂ nanoflake, an electronically conductive metal-organic framework (MOF), has a periodically arranged porous structure with a cavity size of 2 nm, which not only accommodates a large amount of Ru(bpy)₃²⁺ but also confines the spatial diffusion of active species. Therefore, the Ru(bpy)₃²⁺-loaded Cu₃(HHTP)₂ nanocomplex (Ru@CuMOF) as an ECL emitter exhibits an enhanced ECL efficiency. The ECL resonance energy transfer (ECL-RET) was accomplished by combining Ru@CuMOF used as a donor with gold nanoparticles-functionalized graphene oxide nanosheets (GO-Au) utilized as an acceptor. This should be ascribed to the fact that the ECL emission spectrum of Ru@CuMOF shows the strongest signal intensity at 615 nm, overlapping with the absorption spectrum of GO-Au at 580-680 nm. Targeted detection of CRP in human serum samples was achieved by the sandwich-type immunosensor based on the ECL-RET mechanism with a 0.26 pg mL^-1 detection limit. The electro-activated hybrids of Cu₃(HHTP)₂ and ECL emitters provide a new sensing strategy for the high-sensitivity detection of disease markers.

Coupled electrochemiluminescent and resonance energy transfer determination of microRNA-141 using functionalized Mxene composite

The electrochemiluminescence and resonance energy transfer (ECL-RET) method was adopted to detect miRNAs, in which the two-dimensional Ti₃C₂ Mxenes with high surface area modified with CdS:W nanocrystals (CdS:W NCs) were used as ECL signal emitter. Mxenes with a specific surface area of 5.2755 m²/g carried more emitters and promote ECL intensity. As an energy acceptor, BiOCl nanosheets (BiOCl NSs) have a wide UV-Vis absorption peak in the range 250 nm-700 nm, including the emission band of CdS:W NCs with 520 nm emission wavelength. Hence, BiOCl NSs are covalently bound to hairpin DNA 2 by amide bond to quench the ECL signal of CdS:W NCs. In the presence of miRNA-141, the hairpin DNA 1 modified on the GCE was unfold and then paired with hairpin DNA 2 to release miRNA-141 and quench the signal of the ECL biosensor. Then, the concentration signal of miRNA-141 was amplified by catalytic hairpin assembly. The novel specific biosensor demonstrated a satisfactory linear relationship with miRNA-141 in the range 0.6 pM to 4000 pM; the detection limit was as low as 0.26 pM (3 s/m) under the potential of 0 ~ -1.3 V and showed outstanding RSD of 1.19%. The findings of the present work with high accuracy and sensitivity will be of positive significance for the clinical diagnosis of miRNA in the future work. The construction process of the biosensor and electrochemiluminescence mechanism.

A novel electrochemiluminescence immunoassay based on highly efficient resonance energy transfer for florfenicol detection

A novel competitive mechanism electrochemiluminescence (ECL) immunoassay based on resonance energy transfer was used to detect florfenicol for the first time. In this work, CeO₂@TiO₂ nanocomposite, which was used as a donor, was prepared in sol-gel method and the effective band gap of TiO₂ could be reduced by CeO₂, which promoted the ECL emission of TiO₂ and made the ECL performance of the donor more outstanding. The absorption spectrum of Cu₂S and the ECL emission spectrum of the donor could be highly matched, which ensured the occurrence of electrochemiluminescence resonance energy transfer (ECL-RET). In addition, the snowflake-like structure of cuprous sulfide could load more antibodies. It is worth mentioning that as far as we know, there have been no reports of this material as an ECL receptor before. Furthermore, the ECL-RET system based on this has shown excellent performance in the detection of florfenicol. The proposed immunoassay showed satisfactory sensitivity with a wide linear range from 0.001 to 1000 ng mL^-1 and a low detection limit (0.3 pg mL^-1). Due to the remarkable quenching effect and simple assembly process, the immunoassay is of great practical significance and has reference value for the detection of florfenicol or other biological small molecules.

An electrochemiluminescence energy resonance transfer system for highly sensitive detection of brombuterol

In this work, an electrochemiluminescence resonance energy transfer (ECL-RET) system was established based on the modified graphite phase carbon nitride to detect brombuterol residues in food. The ultrasonic-assisted acidification exfoliation modification improved the conductivity and specific surface area of the graphite phase carbon nitride (g-C₃N₄). In addition, the carboxylated g-C₃N₄ nanosheets as ECL donors and the Au-Ag alloy nanoparticles as ECL acceptors could respectively directly carry antigen and antibody. Therefore, the trouble of introducing additional bridge molecules was avoided. A competitive immunoassay strategy was used for the detection of brombuterol, where brombuterol in the sample would compete with the coating antigen for the limited binding sites on antibody. The proposed ECL immunosensor for brombuterol detection exhibited high sensitivity with a wide linear range from 0.001 ng mL^-1 to 1000 ng mL^-1 and a low detection limit at 0.31 pg mL^-1. This work adopts a very simple way to design the sensor without losing its sensitivity, bringing convenience to its possible future applications.

An "on-off" electrochemiluminescence immunosensor for PIVKA-II detection based on the dual quenching of CeO2-Au-g-C3N4 hybrids by Ag nanocubes-VB2

Herein, we report a novel dual-quenching electrochemiluminescence (ECL) immunosensor for detecting protein induced by vitamin K absence or antagonist-II (PIVKA-II) based on ECL resonance energy transfer (ECL-RET). In this protocol, self-accelerated ECL hybrids of CeO₂ and Au nanoparticles functionalized g-C₃N₄ nanosheets (CeO₂-Au-g-C₃N₄) were prepared, which exhibited high ECL emission in the presence of S₂O₈^2- as a coreactant for "signal on" state. Concretely, CeO₂ with a reproducible redox couple of Ce³⁺ and Ce⁴⁺ could act as an efficient co-reaction accelerator to generate more oxidizing intermediate (SO₄^•-) to significantly self-promote the ECL emission of g-C₃N₄ NSs/S₂O₈^2- ECL system. Besides, Au nanoparticles not only accelerated electron transfer in the ECL process, but also provided massive active sites for biomolecules immobilization. The dual quenching labels of Ag nanocubes modified with vitamin B₂ (AgNCs-VB₂) were firstly proposed towards g-C₃N₄ NSs/S₂O₈^2- ECL system by ECL-RET, resulting in the remarkable ECL decrease for "signal off" state. Based on the sandwich immunoreaction, the "on-off" PIVKA-II ECL immunosensor gratifyingly possessed excellent detection sensitivity with the linear range of 0.4 pg mL^-1-10 ng mL^-1 and the low detection limit of 28.46 fg mL^-1 (S/N = 3). This presented strategy might provide a potential alternative tool for PIVKA-II detection in medical research and early clinical diagnostics of hepatocellular carcinoma.